ARALEZ PHARMACEUTICALS INC. overview

Nuvo Pharmaceuticals™ Announces the Filing of the Business Acquisition Report Related to the Acquisition of Aralez Pharmaceuticals Canada, U.S. and International Rights to Vimovo® and other Related Assets PR Newswire MISSISSAUGA, ON, March 15, 2019 MISSISSAUGA, ON , March 15, 2019 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI; OTCQX:NRIFF) today announced the filing of the Business Acquisition Report (BAR) on SEDAR ( www.sedar.com ) related to the previously...

Nuvo Pharmaceuticals™ to Host Conference Call/Audio Webcast to Discuss the Acquisition of Aralez Pharmaceuticals Canada, U.S. and International Rights to Vimovo® and other Related Assets PR Newswire MISSISSAUGA, ON, Jan. 2, 2019 - January 2 at 8:30 a.m. ET - MISSISSAUGA, ON , Jan. 2, 2019 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI; OTCQX:NRIFF), a globally focused, Canadian healthcare company with a portfolio of commercial products will be hosting a conference...

Nuvo Pharmaceuticals™ Announces Completion of the Acquisition of Aralez Pharmaceuticals Canada, U.S. and International Rights to Vimovo® and other Related Assets PR Newswire MISSISSAUGA, ON, Dec. 31, 2018 - Acquisition expected to result in significant expansion of revenue and adjusted EBITDA - - Acquisition includes more than 20 revenue-generating products - - Acquisition expected to provide platform for future growth - - Acquisition financing provided by Deerfield Management Company, L.P. ,...

Nuvo Pharmaceuticals™ Declared Winning Bidder to Acquire Commercial Products from Aralez Pharmaceuticals PR Newswire MISSISSAUGA, ON, Nov. 29, 2018 - Transaction subject to court approval and other customary conditions - - Closing anticipated by year end - MISSISSAUGA, ON , Nov. 29, 2018 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI; OTCQX:NRIFF), a globally focused, healthcare company with a portfolio of commercial products and pharmaceutical manufacturing...

Nuvo Pharmaceuticals™ Announces Signing of Definitive Agreements to Acquire Commercial Products and Infrastructure from Aralez Pharmaceuticals PR Newswire MISSISSAUGA, ON, Sept. 19, 2018 – Would result in significant expansion of revenue and adjusted EBITDA – – Would provide platform for future growth – – Acquisition financing commitment from Deerfield, a leading, global, healthcare-specialized investor – MISSISSAUGA, ON , Sept. 19, 2018 /PRNewswire/ - Nuvo Pharmaceuticals Inc....

...

...

Nuvo Pharmaceuticals™ Announces Letter of Intent to Acquire Commercial Products and Infrastructure from Aralez Pharmaceuticals PR Newswire MISSISSAUGA, ON, Aug. 10, 2018 - Would result in significant expansion of revenue and adjusted EBITDA – - Would provide platform for future growth - Acquisition funding proposed to be provided by Deerfield , a leading, global, healthcare-specialized investor – MISSISSAUGA, ON , Aug. 10, 2018 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company)...